Recent investigations have revealed that CKD patients exhibit increased intracellular AnxA1 expression in neutrophils, coupled with decreased membrane-bound and secreted AnxA1, suggesting compromised utilization of AnxA1’s anti-inflammatory and pro-resolving functions (164). The gene discussed is ANXA1; the disease is chronic kidney disease.